Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Alifrangis

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 6, 2011
Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromesSinéad M Murphy, Usman Khan, Constantine Alifrangis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2015
BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma modelDaniele Perna, Florian A Karreth, Alistair G Rust, et al.
BJUI Compass|August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumoursNasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
Frontiers in Oncology|February 2, 2023
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancerCaitlin R Davies, Tianyu Guo, Edwina Burke, et al.
Nature Genetics|December 10, 2013
Inactivating CUX1 mutations promote tumorigenesisChi C Wong, Inigo Martincorena, Alistair G Rust, et al.
World Journal of Urology|October 2, 2021
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissectionsPaul Lloyd, Anne Hong, Marc A Furrer, et al.
Genome Research|February 10, 2017
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutationsJonathan S Brammeld, Mia Petljak, Inigo Martincorena, et al.
Frontiers in Cell and Developmental Biology|January 25, 2021
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA SequencingTianyu Guo, Yang Wang, Jing Jia, et al.
Urologic Oncology|January 5, 2021
Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus studyOmer Onur Cakir, Fabio Castiglione, Zafer Tandogdu, et al.
Nature Cancer|May 15, 2026
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort studyAnuradha Jayaram, Memuna Rashid, Alison H M Reid, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Neurology, Neurosurgery, and Psychiatry|January 6, 2011
Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromesSinéad M Murphy, Usman Khan, Constantine Alifrangis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2015
BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma modelDaniele Perna, Florian A Karreth, Alistair G Rust, et al.
BJUI Compass|August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumoursNasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
Frontiers in Oncology|February 2, 2023
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancerCaitlin R Davies, Tianyu Guo, Edwina Burke, et al.
Nature Genetics|December 10, 2013
Inactivating CUX1 mutations promote tumorigenesisChi C Wong, Inigo Martincorena, Alistair G Rust, et al.
World Journal of Urology|October 2, 2021
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissectionsPaul Lloyd, Anne Hong, Marc A Furrer, et al.
Genome Research|February 10, 2017
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutationsJonathan S Brammeld, Mia Petljak, Inigo Martincorena, et al.
Frontiers in Cell and Developmental Biology|January 25, 2021
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA SequencingTianyu Guo, Yang Wang, Jing Jia, et al.
Urologic Oncology|January 5, 2021
Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus studyOmer Onur Cakir, Fabio Castiglione, Zafer Tandogdu, et al.
Nature Cancer|May 15, 2026
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort studyAnuradha Jayaram, Memuna Rashid, Alison H M Reid, et al.
Pageof 6